PL3189072T3 - Analogi peptydowe gip - Google Patents

Analogi peptydowe gip

Info

Publication number
PL3189072T3
PL3189072T3 PL15775370T PL15775370T PL3189072T3 PL 3189072 T3 PL3189072 T3 PL 3189072T3 PL 15775370 T PL15775370 T PL 15775370T PL 15775370 T PL15775370 T PL 15775370T PL 3189072 T3 PL3189072 T3 PL 3189072T3
Authority
PL
Poland
Prior art keywords
peptide analogues
gip peptide
gip
analogues
peptide
Prior art date
Application number
PL15775370T
Other languages
English (en)
Inventor
Alexander Hovard SPARRE-ULRICH
Mette Marie Rosenkilde
Jens Juul Holst
Filip Krag KNOP
Mikkel Bring CHRISTENSEN
Lærke Smidt GASBJERG
Original Assignee
Univ Copenhagen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Copenhagen filed Critical Univ Copenhagen
Publication of PL3189072T3 publication Critical patent/PL3189072T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
PL15775370T 2014-09-05 2015-09-07 Analogi peptydowe gip PL3189072T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201470545 2014-09-05
PCT/DK2015/050266 WO2016034186A1 (en) 2014-09-05 2015-09-07 Gip peptide analogues
EP15775370.8A EP3189072B1 (en) 2014-09-05 2015-09-07 Gip peptide analogues

Publications (1)

Publication Number Publication Date
PL3189072T3 true PL3189072T3 (pl) 2019-04-30

Family

ID=54256456

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15775370T PL3189072T3 (pl) 2014-09-05 2015-09-07 Analogi peptydowe gip

Country Status (5)

Country Link
US (2) US10968266B2 (pl)
EP (2) EP3530671A3 (pl)
ES (1) ES2685987T3 (pl)
PL (1) PL3189072T3 (pl)
WO (1) WO2016034186A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3530671A3 (en) 2014-09-05 2019-11-13 University of Copenhagen Gip peptide analogues
JOP20180028A1 (ar) 2017-03-31 2019-01-30 Takeda Pharmaceuticals Co مركب ببتيد
BR112019025195A8 (pt) 2017-05-31 2020-07-07 Univ Copenhagen análogos do peptídeo gip de ação prolongada
CN112074531A (zh) 2018-05-04 2020-12-11 诺和诺德股份有限公司 Gip衍生物及其用途
US20220298218A1 (en) * 2018-12-03 2022-09-22 Antag Therapeutics Aps Modified GIP Peptide Analogues
WO2021110845A1 (en) 2019-12-03 2021-06-10 Antag Therapeutics Aps Optimized gip peptide analogues

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869602A (en) 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
US6458924B2 (en) 1996-08-30 2002-10-01 Novo Nordisk A/S Derivatives of GLP-1 analogs
US6384016B1 (en) 1998-03-13 2002-05-07 Novo Nordisk A/S Stabilized aqueous peptide solutions
US6268343B1 (en) 1996-08-30 2001-07-31 Novo Nordisk A/S Derivatives of GLP-1 analogs
BRPI9711437B8 (pt) 1996-08-30 2021-05-25 Novo Nordisk As derivados de glp-1
AU5518798A (en) 1996-12-03 1998-06-29 Trustees Of Boston University Specific antagonists for glucose-dependent insulinotropic polypeptide (gip)
PL191327B1 (pl) 1998-01-30 2006-04-28 Novo Nordisk As Strzykawka do podawania ustalonych dawek lekarstwa z naboju
EP1056775B1 (en) 1998-02-27 2010-04-28 Novo Nordisk A/S Glp-1 derivatives of glp-1 and exendin with protracted profile of action
JP2002526554A (ja) 1998-10-07 2002-08-20 メディカル カレッジ オブ ジョージア リサーチ インスティチュート，インコーポレイテッド 骨親和性ホルモンとして用いられるグルコース依存性インスリン親和性ペプチド
NZ527241A (en) 1998-12-07 2004-12-24 Sod Conseils Rech Applic Analogues of GLP-1
PT1171465E (pt) 1999-03-29 2004-12-31 Uutech Ltd Analogos de petido inibidor gastrico e sua utilizacao para o tratamento de diabetes
US20050272652A1 (en) 1999-03-29 2005-12-08 Gault Victor A Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
WO2002046227A2 (en) 2000-12-07 2002-06-13 Eli Lilly And Company Glp-1 fusion proteins
US20030232761A1 (en) 2002-03-28 2003-12-18 Hinke Simon A. Novel analogues of glucose-dependent insulinotropic polypeptide
US20050059605A1 (en) * 2003-01-31 2005-03-17 Krishna Peri Chemically modified metabolites of regulatory peptides and methods of producing and using same
CA2597649A1 (en) 2005-02-11 2006-08-17 Amylin Pharmaceuticals, Inc. Gip analog and hybrid polypeptides with selectable properties
US8263545B2 (en) 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
TWI372629B (en) 2005-03-18 2012-09-21 Novo Nordisk As Acylated glp-1 compounds
US20090186817A1 (en) 2006-03-21 2009-07-23 Amylin Pharmaceuticals, Inc. Peptide-peptidase inhibitor conjugates and methods of using same
WO2010016936A1 (en) 2008-08-07 2010-02-11 Ipsen Pharma S.A.S. Pharmaceutical compositions of analogues of glucose-dependent insulinotropic polypeptide
EP2987805A3 (en) 2008-08-07 2016-04-13 Ipsen Pharma S.A.S. Analogues of glucose-dependent insulinotropic polypeptide
MX2011001028A (es) 2008-08-07 2011-04-26 Ipsen Pharma Sas Analogos truncados de polipeptidos de insulinotropicos dependientes de glucosa.
EP2318433A4 (en) 2008-08-07 2012-08-08 Ipsen Pharma Sas GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE ANALOGUES (GIP) MODIFIED AT THE N-TERMINAL END
JP2011530507A (ja) 2008-08-07 2011-12-22 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ グルコース依存性インスリン分泌刺激ポリペプチドアナログ
US9023986B2 (en) * 2010-10-25 2015-05-05 Hoffmann-La Roche Inc. Glucose-dependent insulinotropic peptide analogs
AR084558A1 (es) 2010-12-22 2013-05-22 Marcadia Biotech Metodos para tratar trastornos metabolicos y obesidad con peptidos basados en glucagon activos para el receptor de peptido insulinotropico dependiente de glucosa (gip)/peptido-1 similar al glucagon (glp-1)
WO2012167744A1 (en) * 2011-06-10 2012-12-13 Beijing Hanmi Pharmaceutical Co., Ltd. Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof
EP3530671A3 (en) 2014-09-05 2019-11-13 University of Copenhagen Gip peptide analogues
BR112017008659A2 (pt) 2014-10-29 2018-01-30 Zealand Pharma As ?métodos e compostos de agonista de gip?
US20190000928A1 (en) 2015-06-17 2019-01-03 The California Institute For Biomedical Research Modified therapeutic agents and compositions thereof
CN110099694A (zh) 2016-12-26 2019-08-06 花王株式会社 低体温改善剂
JP7165495B2 (ja) 2016-12-26 2022-11-04 花王株式会社 運動調節機能向上剤
JP7165496B2 (ja) 2016-12-26 2022-11-04 花王株式会社 認知機能改善剤
BR112019025195A8 (pt) 2017-05-31 2020-07-07 Univ Copenhagen análogos do peptídeo gip de ação prolongada

Also Published As

Publication number Publication date
EP3530671A2 (en) 2019-08-28
EP3530671A3 (en) 2019-11-13
US10968266B2 (en) 2021-04-06
WO2016034186A1 (en) 2016-03-10
EP3189072B1 (en) 2018-07-18
ES2685987T3 (es) 2018-10-15
US20210340211A1 (en) 2021-11-04
EP3189072A1 (en) 2017-07-12
US20180258152A1 (en) 2018-09-13

Similar Documents

Publication Publication Date Title
GB201418562D0 (en) Peptides
GB201520559D0 (en) Peptides
PL3189072T3 (pl) Analogi peptydowe gip
GB201520536D0 (en) Peptides
GB201401877D0 (en) Peptides
ZA201607059B (en) Omega-3 analogues
GB201520563D0 (en) Peptides
GB201520545D0 (en) Peptides
GB201520546D0 (en) Peptides
GB201520543D0 (en) Peptides
GB201520544D0 (en) Peptides
GB201520539D0 (en) Peptides
GB201520541D0 (en) Peptides
GB201520562D0 (en) Peptides
GB201520550D0 (en) Peptides
HK1253316A1 (zh) 肽
GB201503483D0 (en) Novel Antimmicrobial Peptides
GB201520558D0 (en) Peptides
GB201520557D0 (en) Peptides
GB201520548D0 (en) Peptides
GB201520542D0 (en) Peptides
GB201406581D0 (en) PAP Peptide analogues
GB201409536D0 (en) Chemically modifying peptides
GB201401673D0 (en) Esculentin-2CHa peptide and analogues thereof
GB201520535D0 (en) Peptides